scholarly journals High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy

2018 ◽  
Vol 70 (4) ◽  
pp. 594-605 ◽  
Author(s):  
Nirit Mor-Vaknin ◽  
Miguel Rivas ◽  
Maureen Legendre ◽  
Smriti Mohan ◽  
Ye Yuanfan ◽  
...  
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Early Disease ◽  
Polyarticular Juvenile Idiopathic Arthritis ◽  
Factor Therapy ◽  
Necrosis Factor

Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients

2017 ◽  
Vol 69 (3) ◽  
pp. 668-675 ◽  
Author(s):  
Vanesa Calvo-Río ◽  
Montserrat Santos-Gómez ◽  
Inmaculada Calvo ◽  
M. Isabel González-Fernández ◽  
Berta López-Montesinos ◽  
...  
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Tumor Necrosis Factor ◽  
Multicenter Study ◽  
Interleukin 6 ◽  
Tumor Necrosis ◽  
Interleukin 6 Receptor ◽  
Factor Therapy ◽  
Necrosis Factor

scholarly journals Genotoxicity of anti–tumor necrosis factor therapy in patients with juvenile idiopathic arthritis

2010 ◽  
Vol 62 (1) ◽  
pp. 73-77 ◽  
Author(s):  
Erkan Demirkaya ◽  
Ismet Cok ◽  
Emre Durmaz ◽  
Onur K. Ulutas ◽  
Nuray Aktay Ayaz ◽  
...  
Keyword(s):  
Juvenile Idiopathic Arthritis ◽  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Factor Therapy ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document